CMS Issues 2026 Physician Fee Schedule Final Rule

November 13, 2025

Medicare

On Oct. 31, the Centers for Medicare & Medicaid Services (CMS) released the CY 2026 Medicare Physician Fee Schedule Final Rule, which outlines payment and policy updates for services furnished on or after Jan. 1, 2026, under Medicare Part B. The rule was largely finalized as proposed with some modifications. In response to stakeholder concerns, CMS decided against changes to Bona Fide Service Fees and Fair Market Value definitions.

The agency finalized the proposed 340B changes with some modifications, including its proposal to create a voluntary claims data repository (with privacy safeguards). CMS also finalized Average Sales Price updates, such as inclusion of Maximum Fair Price units, bundled pricing guidance, and continuation of existing payment policies for autologous cell and gene therapies, while holding back proposals that would have reclassified certain payments.

CMS finalized an increase in physician fee schedule (PFS) payment rates for 2026 that reflects statutory updates. However, the agency finalized rate cuts for most specialists through an efficiency adjustment and site-of-service differential policy despite significant pushbacks. As widely expected, the agency also finalized a proposal to reduce payments for skin substitutes by roughly 90% using a flat fee model. The final rule includes several provisions that reaffirm CMS’ commitment to advancing digital and virtual care, broadening reimbursement pathways, making select flexibilities permanent, and simplifying administrative processes to support continued access and innovation.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like